Lupin's Pithampur facility completes USFDA inspection with 3 observations

Barchart · 09/28 04:46
Lupin announced that its Pithampur facility in Madhya Pradesh, which includes the unit-1 API and finished product manufacturing site, was inspected by the U.S. Food and Drug Administration (USFDA) from 16 September to 27 September 2024.